BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22008134)

  • 1. [Age and sex variations of HbA(1C) in a French population without known diabetes aged 6 to 79 years].
    Gusto G; Vol S; Born C; Balkau B; Lamy J; Bourderioux C; Lantieri O; Tichet J
    Ann Biol Clin (Paris); 2011; 69(5):545-53. PubMed ID: 22008134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
    Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
    Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between glycated hemoglobin and glucose concentrations in the adult Galician population: selection of optimal glycated hemoglobin cut-off points as a diagnostic tool of diabetes mellitus.
    Botana López MA; López Ratón M; Tomé MA; Fernández Mariño A; Mato Mato JA; Rego Iraeta A; Pérez Fernández R; Cadarso Suárez C
    Endocrinol Nutr; 2012 Oct; 59(8):496-504. PubMed ID: 22857908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HbA1c 5·7-6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.
    Heianza Y; Hara S; Arase Y; Saito K; Fujiwara K; Tsuji H; Kodama S; Hsieh SD; Mori Y; Shimano H; Yamada N; Kosaka K; Sone H
    Lancet; 2011 Jul; 378(9786):147-55. PubMed ID: 21705064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey.
    Bao Y; Ma X; Li H; Zhou M; Hu C; Wu H; Tang J; Hou X; Xiang K; Jia W
    BMJ; 2010 May; 340():c2249. PubMed ID: 20478961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.
    Soulimane S; Simon D; Shaw JE; Zimmet PZ; Vol S; Vistisen D; Magliano DJ; Borch-Johnsen K; Balkau B
    Diabet Med; 2011 Nov; 28(11):1311-8. PubMed ID: 21824186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased HbA1c diagnostic specificity.
    Dubowitz N; Xue W; Long Q; Ownby JG; Olson DE; Barb D; Rhee MK; Mohan AV; Watson-Williams PI; Jackson SL; Tomolo AM; Johnson TM; Phillips LS
    Diabet Med; 2014 Aug; 31(8):927-35. PubMed ID: 24698119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
    Jesudason DR; Dunstan K; Leong D; Wittert GA
    Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus.
    Schöttker B; Müller H; Rothenbacher D; Brenner H
    Diabetologia; 2013 Jan; 56(1):92-100. PubMed ID: 22986731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice.
    Bernal-Lopez MR; Santamaría-Fernandez S; Lopez-Carmona D; Tinahones FJ; Mancera-Romero J; Peña-Jimenez D; Jansen-Chaparro S; Baca-Osorio AJ; Cuesta-Muñoz AL; Serrano-Rios M; Gomez-Huelgas R
    Diabet Med; 2011 Nov; 28(11):1319-22. PubMed ID: 21966956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One in five laboratories using various hemoglobin A1c methods do not meet the criteria for optimal diabetes care management.
    Lenters-Westra E; Weykamp C; Schindhelm RK; Siebelder C; Bilo HJ; Slingerland RJ
    Diabetes Technol Ther; 2011 Apr; 13(4):429-33. PubMed ID: 21355726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimester-specific reference intervals for IFCC standardised haemoglobin A(1c): new criterion to diagnose gestational diabetes mellitus (GDM)?
    O'Shea P; O'Connor C; Owens L; Carmody L; Avalos G; Nestor L; Lydon K; Dunne FP
    Ir Med J; 2012 May; 105(5 Suppl):29-31. PubMed ID: 22838107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
    Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
    Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations.
    Manley SE; Sikaris KA; Lu ZX; Nightingale PG; Stratton IM; Round RA; Baskar V; Gough SC; Smith JM
    Diabet Med; 2009 Feb; 26(2):115-21. PubMed ID: 19236612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ageing and associations of fasting plasma glucose and 2 h plasma glucose with HbA(1C) in apparently healthy population. "FIN-D2D" study.
    Saltevo JT; Kautiainen H; Niskanen L; Oksa H; Puolijoki H; Sundvall J; Keinänen-Kiukaanniemi S; Peltonen M; Tuomilehto J; Uusitupa M; Mäntyselkä P; Vanhala MJ
    Diabetes Res Clin Pract; 2011 Sep; 93(3):344-9. PubMed ID: 21632144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes?
    Narbonne H; Renacco E; Pradel V; Portugal H; Vialettes B
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):598-603. PubMed ID: 11694860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
    Inoue K; Matsumoto M; Akimoto K
    Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of diabetes estimated by plasma glucose criteria combined with standardized measurement of HbA1c among health checkup participants on Miyako Island, Japan.
    Takahashi Y; Noda M; Tsugane S; Kuzuya T; Ito C; Kadowaki T
    Diabetes Care; 2000 Aug; 23(8):1092-6. PubMed ID: 10937503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.